Related by context. All words. (Click for frequent words.) 68 intranasal ketamine 67 Dyloject TM 66 intranasal formulation 63 corticotropin injection 62 BUPHENYL R 62 SPRYCEL ® 62 Q#IR 62 phase IIb trial 62 oxymorphone ER 62 non nucleoside inhibitor 61 Phase 2a clinical trials 61 markets HP Acthar 61 CRMD# 61 SinuNase TM 61 Submits Response 61 POSIDUR TM 61 CAELYX 60 Gel repository corticotropin injection 60 oxycodone acetaminophen 60 LEP ETU 60 arsenic trioxide injection 60 OvaRex ® MAb 60 treat chronic sinusitis 60 azilsartan medoxomil 60 Pafuramidine 60 PDX pralatrexate 60 RAPTIVA 60 HFA MDI 60 MAGE A3 ASCI 60 orally inhaled 60 IMiDs ® compound 60 im peramivir 60 Zenvia ™ 60 DDP# 60 severe hypercholesterolemia 59 initiate Phase IIa 59 LEVAQUIN ® 59 forodesine 59 5 HT3 antagonist 59 phase IIb study 59 Zemiva TM 59 Cleviprex TM clevidipine 59 SinuNase ™ 59 TRANSDUR ® 59 Panzem R NCD 59 Cintredekin besudotox 59 Targretin capsules 59 Dementia Related Psychosis 59 Zemplar Capsules 59 Orally administered 59 Panzem R 59 phase III isavuconazole 59 Cloretazine 59 acetonide FA 59 short acting bronchodilator 59 ruxolitinib 59 pregabalin Lyrica 59 Cloretazine ® 59 Phase Ib study 59 highly purified pasteurized 59 histamine dihydrochloride 59 ACAPODENE TM 59 UPLYSO 59 peripherally acting 59 HEPLISAV TM 59 Plicera 58 KAPVAY ™ 58 ZOMIG 58 administered intramuscularly 58 novel emulsion formulation 58 Androgel R 58 midstage clinical 58 Chemophase 58 cannabinor 58 successfully commercialize Iluvien 58 2 methoxyestradiol 58 DURIN TM 58 CLIRS 58 5mg #mg 58 R palivizumab 58 pharmacologically active isomer 58 BLA filing 58 Phase #b/#a clinical 58 Xcytrin R 58 NeuroSTAT ® 58 GLP toxicology studies 58 dextromethorphan quinidine 58 Prosaptide 58 Saquinavir 58 Insulin PH# 58 ORENCIA R 58 phase Ib 58 5 lipoxygenase inhibitor 58 Phase IIb clinical trials 58 epoetin alpha 58 Phase IIA 58 Phase 1a clinical 58 bolus dose 58 Phase #b/#a trial 58 PEG PAL 58 SAR# [004] 58 Phase Ib II 58 salmeterol fluticasone 58 Known hypersensitivity 58 2A receptor agonist 58 torsemide ER 58 CINTREDEKIN BESUDOTOX 58 MEK Inhibitor 58 certolizumab 58 INVEGA ® 58 pegylated alpha interferon 58 lingual spray 58 AAG geldanamycin analog 57 Alexza Staccato 57 CHAMPION PCI 57 gemtuzumab ozogamicin 57 ZANAFLEX CAPSULES ® tizanidine 57 intradermal injections 57 evaluating tivozanib 57 mg/m2 cohort 57 Tarceva TM 57 PANVAC VF 57 Cimzia TM 57 ALN HPN 57 hemagglutination inhibition HAI 57 orally disintegrating 57 candidate TNFerade biologic 57 treatment naive genotype 57 OVATURE 57 Zemiva ™ 57 AMEVIVE 57 Perforomist ™ Inhalation Solution 57 cromolyn sodium 57 Hematide ™ peginesatide 57 TRANSDUR ™ 57 sitaxsentan 57 subcutaneous dosing 57 REVEAL Registry 57 NicVAX TM 57 desvenlafaxine succinate 57 brivaracetam 57 urocortin 2 57 personalized dendritic cell 57 Forodesine HCl 57 TELINTRA 57 relapsed MM 57 SPRIX ® 57 generation purine nucleoside 57 telaprevir VX 57 docetaxel Taxotere ® 57 Efficacy Trial 57 opioid induced bowel dysfunction 57 Diamyd r 57 initiated Phase Ib 57 Mesafem 57 antiepileptics 57 Anturol TM 57 severe hypersensitivity reactions 57 hoFH 57 selective phosphodiesterase 57 estramustine 57 fosbretabulin 57 velafermin 57 TLK# 57 Phase #b/#a 57 Phase IIb trials 57 FUSILEV ® 57 PNP inhibitor 57 pioglitazone hydrochloride 57 Telik logo TELINTRA 57 Soliris TM eculizumab 57 Phase III Clinical Trials 57 FOLFOX6 chemotherapy regimen 57 Toremifene 57 Androxal TM 57 eFlow R 57 IL# PE#QQR 57 topically administered 57 Plenaxis TM 57 CLIRS trial 57 orally administered inhibitor 57 AGILECT R 56 albiglutide 56 #mg #mg #mg [003] 56 refractory chronic lymphocytic 56 Urocortin 2 56 AIR CF1 56 lenalidomide Revlimid R 56 aplindore 56 TRISENOX R 56 Abrupt discontinuation 56 randomized Phase IIb 56 XOMA 3AB 56 palonosetron hydrochloride injection 56 #I TM# 56 Flovent HFA 56 AIMM trial 56 mitoxantrone plus 56 Proellex TM 56 trastuzumab DM1 T DM1 56 transmucosal delivery system 56 hyperphenylalaninemia HPA due 56 ACAPODENE 56 Trofex ™ 56 ELADUR 56 oral prodrug 56 recurrent herpes labialis 56 Phase Ib clinical 56 IV bolus 56 Apoptone 56 EVIZON ™ 56 gluteal injection 56 lorvotuzumab mertansine 56 Temsirolimus 56 hypoxia activated prodrug 56 including eniluracil ADH 56 catheter occlusion 56 lintuzumab SGN 56 Silenor ® 56 PROSTASCINT R 56 alvespimycin 56 intravenously administered 56 Testosterone MDTS ® 56 FOLOTYN ® 56 ritonavir boosted protease inhibitor 56 BiovaxID TM 56 rALLy clinical trial 56 pharmacodynamic PD 56 Somatuline R Autogel R 56 Cites Positive 56 Allovectin 7 56 ALN HTT 56 Empatic ™ 56 RISPERDAL ® CONSTA ® 56 TOCOSOL Camptothecin 56 Triapine R 56 receptor tyrosine kinase inhibitor 56 huC# DM4 56 REVIVE Diabetes 56 commercialize ZYFLO CR 56 XL# anticancer compounds 56 vaginally administered lidocaine 56 Evoltra ® 56 oral transmucosal 56 de novo kidney transplant 56 sNDAs 56 Telintra 56 rhIGF-I/rhIGFBP-3 56 Phase 2a trial 56 mild hepatic impairment 56 phase IIa 56 please visit http:/www.atherogenics.com 56 Bicifadine 56 administered intranasally 56 brand ciclesonide HFA 56 BUPHENYL 56 dose escalation phase 56 phase IIb III 56 midstage trials 56 candidates Azedra TM 56 generation PNP inhibitor 56 PDE4 inhibitor 56 abacavir Ziagen 56 Phase IIa trials 56 ACOMPLIA R 56 ENDEAVOR IV 56 nalbuphine ER 56 anthracycline taxane 56 oral rivaroxaban 56 Phase lll 56 morphine fentanyl 56 bupropion hydrochloride 55 thrombin inhibiting aptamer 55 SEPET TM 55 Daptomycin 55 visit www.sciclone.com 55 intradermal injection 55 injectable biologic 55 XP# XP# 55 platelet aggregation inhibitors 55 5 HT2A inverse 55 omacetaxine mepesuccinate 55 proprietary Capillary Aerosolization Technology 55 MENOPUR 55 R sorafenib tablets 55 Helicobacter pylori eradication 55 SILENOR 55 Phase #/#a 55 Phase IIb III 55 HDAC Inhibitor 55 5 Fluorouracil 55 FUSILEV enhances 55 preclinical efficacy 55 Phase IIB 55 Captisol Enabled 55 AFREZZA Inhalation Powder 55 huN# DM1 55 tizanidine hydrochloride short 55 recurrent glioblastoma multiforme 55 Coadministration 55 PF # [002] 55 LymphoStat B TM 55 Fentanyl TAIFUN R 55 registrational studies 55 interferon gamma 1b 55 erlotinib Tarceva ® 55 KAPIDEX 55 rindopepimut 55 CIMZIA TM 55 oral talactoferrin 55 please visit http:/www.vandapharma.com 55 denileukin diftitox 55 weekly subcutaneous injection 55 R sipuleucel T 55 Somatuline Autogel 55 CUSTOM III 55 Acetavance TM 55 investigational humanized monoclonal antibody 55 subcutaneous insulin 55 IMiDs R 55 PI3K/Akt pathway inhibitor 55 Troxatyl 55 phase IIa clinical 55 Pharmacodynamic 55 dexanabinol 55 CELVAPAN H#N# 55 CD# CEA 55 includes AstraZeneca Accolate 55 intravesical infusion therapy 55 TM pralatrexate injection 55 #mg ATC 55 Intraject 55 NOX E# 55 EDEMA3 55 Annamycin 55 GLP1 agonist 55 candidate XP# 55 Phase III LibiGel 55 JAK inhibitor 55 NP2 Enkephalin 55 AdhTAP 55 Nicotine Conjugate Vaccine 55 CIMZIA ™ 55 CytoFabTM 55 EMSAM 55 uric acid lowering 55 dalteparin 55 canakinumab 55 CNS depressant 55 mycophenolate mofetil MMF 55 Altera Nebulizer System 55 R lenalidomide 55 developing ACAPODENE 55 tumor lysis syndrome 55 Excellagen 55 rheumatoid arthritis osteoarthritis ankylosing 55 indiplon capsules 55 subcutaneous formulation 55 ANCHOR trial 55 bolus injection 55 TransVax tm 55 lomitapide 55 BrachySil TM 55 TRO# 55 Specifid 55 olanzapine LAI 55 Critical Therapeutics Zyflo 55 dosing cohort 55 ocular formulation 55 pancrelipase 55 BiDil XR 55 Intranasal 55 ularitide 55 ACR# ACR# 55 fentanyl citrate 55 antidepressants fluoxetine 55 Solazed 55 faropenem 55 budesonide foam 55 Nasdaq OPTR 55 ritonavir boosted 55 Allovectin 7 r 55 EGS# 55 Phase IIIb clinical 55 MGd 55 Traficet EN 55 zileuton CR 54 ARIKACE ™ 54 buprenorphine naloxone 54 AZX# 54 Phase IIa clinical trials 54 multicenter Phase II 54 rilonacept 54 ELADUR ™ 54 Entereg R 54 GOUT 54 Omigard 54 R pramlintide acetate 54 mg hydrochlorothiazide 54 darunavir r 54 injected subcutaneously 54 Tenofovir Disoproxil Fumarate 54 Anturol ® 54 MVA MUC1 IL2 54 PSMA ADC 54 controlled analgesia PCA 54 moderate hepatic impairment 54 balsalazide tablet 54 SUBOXONE 54 5mg dose 54 vosaroxin 54 confirmatory clinical 54 subcutaneous SC 54 APTIVUS ritonavir 54 MCSP respectively 54 R Saizen R 54 Ventolin HFA 54 MERLIN TIMI 54 XL# XL# XL# 54 EDEMA3 trial 54 ponatinib 54 elotuzumab 54 Phase III ADT 54 subcutaneous methylnaltrexone 54 Solazed TM 54 valproate sodium 54 LATUDA 54 CB2 selective receptor agonist 54 PULMICORT RESPULES 54 Pharmacokinetic parameters 54 bleeding pallor 54 evaluating bafetinib 54 Sodium oxybate 54 vivo toxicology 54 Bifeprunox 54 synthetic retinoid 54 ATL# [001] 54 MAXY alpha 54 candidate CRLX# 54 epirubicin cisplatin 54 administered subcutaneously 54 Poly ICLC 54 confirmatory Phase III 54 IND Investigational New 54 demonstrated antitumor activity 54 herpetic keratitis 54 Archexin 54 intermittent dosing 54 microtubule inhibitor 54 CYT# potent vascular disrupting 54 relapsed refractory multiple myeloma 54 apoptosis inducer 54 ALN PCS 54 REMOXY ® 54 ENABLE Phase 2 54 biologic antibody 54 panitumumab Vectibix 54 Pyridorin 54 HCV polymerase 54 Spiegelmer ® 54 humanized therapeutic 54 oral methylnaltrexone 54 Benlysta belimumab 54 GRNVAC1 54 Adenoscan 54 R#/MEM # 54 prokinetic 54 Hedgehog antagonist 54 EVIZON TM 54 nalbuphine 54 International LAB Pharma 54 blinded randomized placebo controlled 54 Phase IIIB IV 54 mcg BID 54 Pentacel vaccine 54 riociguat 54 Aquavan 54 MEND CABG II 54 Exherin TM 54 Budesonide foam crofelemer 54 ascending doses 54 Amigal TM 54 UVIDEM 54 Linjeta TM 54 Thorough QT 54 please visit www.advaxis.com 54 #beta estradiol 54 NMDA antagonist 54 Alzhemed TM 54 tiagabine 54 Menerba 54 pharmacogenomic translational research 54 LE SN# 54 VITAL Trial 54 Shire BioChem Inc. 54 POSIDUR TM ELADUR TM 53 antineoplastic 53 MENOPUR ® 53 Veronate R 53 HGS ETR2 53 Navelbine ® 53 SCIg 53 Nasdaq DVAX 53 nucleotide analogue 53 Simulect 53 BRIM3 53 BCR ABL inhibitor 53 candidate AQ4N 53 IIb clinical trial 53 PORxin TM platforms 53 forodesine hydrochloride 53 Augment Injectable 53 Asentar TM 53 TOLAMBA 53 Immunotherapeutic 53 CTAP# Capsules 53 Urocidin 53 receiving XGEVA 53 Auxilium anticipates 53 6R BH4 53 insulin glulisine 53 HuMax TAC 53 Gemzar ® 53 intratympanic 53 PREGNANT Study 53 Active Ulcerative Colitis 53 Zavesca R 53 oral levofloxacin 53 Circadin 53 REVLIMID lenalidomide 53 acetylcholinesterase inhibitor 53 #ug [002] 53 Kahalalide F 53 GENASIS clinical 53 HCD# [002] 53 intranasal insulin 53 registrational 53 Phase 2b kidney transplant 53 ribavirin therapy 53 buccal spray 53 sorafenib tablets 53 subconjunctival injection 53 Bacillus Calmette Guerin 53 ADL# novel 53 Panenza 53 synDNA TM 53 endothelin antagonists 53 piperacillin tazobactam 53 vidofludimus 53 Ramelteon 53 dose cohort 53 postoperative ileus POI 53 cidofovir 53 intravenous dosing 53 anticholinergic agents 53 inhaled formulations 53 8mg/kg 53 Cloretazine R 53 coadministration 53 beta2 agonist 53 GnRH antagonist 53 Troxatyl TM 53 hydroxocobalamin 53 faropenem medoxomil 53 injected intramuscularly 53 orBec ® oral beclomethasone 53 placebo intravenously 53 DermaVir Patch 53 pressurized metered dose 53 INS# [002] 53 alvimopan 53 Plenaxis R 53 limiting toxicity DLT 53 naltrexone hydrochloride 53 Nascobal ® 53 PRIALT 53 HQK 53 TRPV1 agonist 53 FRAGMIN R 53 novel VDA molecule 53 dacarbazine chemotherapy 53 r hGH 53 Phase III Psoriasis 53 5mg/kg 53 Initiate Phase II 53 phase IIb clinical 53 budesonide MMX Phase III 53 Prestara 53 signal detection CTSD 53 refractory gout 53 stated Michelle Berrey 53 IMPACT DCM 53 sterile lidocaine patch 53 BEMA ® 53 Phase III randomized controlled 53 Enhanze Technology 53 MOZOBIL 53 non nucleoside HCV 53 abacavir lamivudine 53 APTIVUS r 53 pomalidomide 53 Neupogen ® 53 PREOS R 53 methylphenidate Ritalin 53 trivalent influenza vaccine 53 containing LABAs 53 Prodarsan R 53 goserelin 53 Phase 1b clinical trials 53 HepeX B 53 hepatitis B immune globulin 53 VIIBRYD 53 AMPAKINE CX# 53 brentuximab vedotin SGN 53 Intravenous immunoglobulin 53 AGGRASTAT R tirofiban hydrochloride 53 GRALISE 53 PDE# inhibitors 53 dihydrochloride Tablets 53 humanised monoclonal antibody 53 please visit www.medicinova.com 53 mg subcutaneous 53 anti Parkinsonian 53 pediatric pontine glioma 53 synthetic opioid 53 Ceplene TM 53 known sulfonamide allergy 53 TDF FTC 53 reuptake inhibitor 53 purine analog 53 Capesaris 53 Emezine R 53 E1 INT TM 53 oncolytic virus therapies 52 VP# [004] 52 Phase 1a 52 TRX1 52 imexon 52 opioid dependent 52 DCVax R Prostate 52 #mg/m# [001] 52 intravenous IV infusion 52 Fibrillex TM 52 prokinetic agent 52 Randomized Clinical Trials 52 BNC# 52 vismodegib 52 number NCT# ClinicalTrials.gov 52 PEP# [003] 52 MEND CABG 52 APEX AMI 52 HepaGam B TM 52 mg/m2 administered 52 incretin mimetic 52 nonhematologic adverse reactions 52 Pharmacokinetic 52 continuous intravenous infusion 52 PCI ExTRACT TIMI 52 Ostabolin C TM 52 Protexia R 52 adjunctively 52 develop HBV reactivation 52 microgram mcg 52 Pegasys ® 52 biologic DMARD 52 ACTOplus met XR 52 tropism testing 52 serum phosphorous 52 TransVax ™ 52 recombinant PSMA vaccine 52 Topical Interferon Alpha 2b 52 octreotide implant 52 alkylating agent 52 KRYSTEXXA TM 52 Protexia ® 52 Inc. www.micromet inc.com 52 metformin accumulation 52 lorazepam Ativan 52 MULTAQ 52 Neupro R 52 systemically administered 52 Triolex 52 AKT inhibitor 52 mg eq 52 nasally delivered 52 induced platelet aggregation 52 guanfacine 52 pharmacokinetic studies 52 recurrent metastatic ovarian cancer 52 lintuzumab 52 Zemiva TM Trofex TM 52 Aquavan Injection 52 GSK# [002] 52 vernakalant hydrochloride 52 Fodosine 52 CALGB # [002] 52 phase IIb 52 REVIVE TA 52 ThermoDox ® clinical 52 leukopenia pancytopenia thrombocytopenia 52 visilizumab 52 AERx iDMS 52 randomized Phase 2b 52 demonstrated clinically meaningful 52 alpha interferons 52 Releases Second Quarter 52 AGGRASTAT ® tirofiban hydrochloride 52 includes TOLAMBA TM 52 initiate multicenter 52 painful diabetic neuropathy 52 Staphylococcus aureus Immune Globulin 52 cathepsin K inhibitor 52 R PEG uricase 52 Pagoclone 52 Phase 1b clinical 52 ALN VSP Phase 52 TELCYTA 52 Preclinical studies suggest 52 please visit http:/www.sunesis.com 52 IOP lowering 52 BoNTA 52 IAP inhibitor 52 Tyzeka Sebivo 52 cisplatin gemcitabine 52 AZT zidovudine 52 3 registrational trial 52 treat dysmenorrhea 52 initiate Phase Ib 52 Progenta TM 52 ISTODAX 52 HGS ETR1 mapatumumab 52 Neurodex TM 52 Phase 1b 52 Pernix Therapeutics 52 Dacogen injection 52 dorzolamide 52 IND submission 52 BioNumerik 52 IEQ kg 52 iii GTx 52 2A agonist 52 samalizumab 52 Hepatotoxicity 52 clinical pharmacology studies 52 endothelin receptor antagonists 52 Diphenhydramine 52 escitalopram oxalate 52 HDL Selective Delipidation 52 CG# [003] 52 motesanib diphosphate 52 polycythemia vera essential thrombocythemia 52 granted Ortec 52 Urocidin TM 52 X Excite 52 Dextofisopam 52 anastrazole 52 GSK# [001] 52 VersaFilm 52 CorVue ™ 52 Phe restricted diet 52 intra nasal 52 Azedra TM Onalta TM 52 eculizumab therapy 52 pyrimidine nucleoside analog 52 R entecavir 52 clomipramine 52 diagnostic radiopharmaceutical 52 FavId 52 nebulization 52 multicenter Phase III 52 loxapine 52 lyophilized powder 52 Phase III TRIST 52 StaphVAX R 52 treatmentof 52 pharmacodynamics PD 52 TAXOTERE R 52 PROMACTA 52 bazedoxifene conjugated estrogens 52 OMS#HP 52 coronary stent merged 52 neutropenia dehydration dyspnea 51 cobiprostone 51 PD2i CA 51 NOXAFIL Oral Suspension 51 PRECISE trial 51 ARIKACE 51 Stimuvax R 51 intravenous bolus 51 #mg doses [002] 51 CCR5 antagonist 51 elvucitabine 51 loperamide 51 Feasibility Trial 51 MDS AML 51 pegylated IFN 51 Taglich Brothers Initiates Coverage 51 www.telik.com 51 preclinical pharmacology 51 opiate painkiller 51 MyVax R 51 Major Depressive Disorder MDD 51 NEUPOGEN 51 subcutaneous dose 51 FOLFOX chemotherapy 51 PEG SN# 51 Trofex 51 pharmacokinetic characteristics 51 intravenous RSD# 51 RSD# oral 51 lesinurad 51 PEARL SC 51 CYT# vascular disrupting 51 PEGylated interferon 51 Actimmune ® 51 SEASONIQUE 51 saline placebo 51 TAXOL 51 oral hypoglycemic 51 Ancrod 51 myocardial infarction ventricular fibrillation 51 developing ostarine selective 51 AQUAVAN R 51 PENNVAX B 51 ancrod 51 PERSEUS 51 Sulonex TM 51 GATTEX ™ 51 dopamine receptor agonist 51 intra articular injection 51 initiate Phase 1b 51 midstage studies 51 talactoferrin 51 LUMINATE 51 system REG1 consists 51 Cariprazine 51 active Gonadotropin Releasing 51 cyclobenzaprine 51 Peg IFN 51 Lipitor #mg 51 Oral corticosteroids 51 Sinks Lower 51 SNALP technology 51 ULTRAM ER 51 Phenoptin 51 HuMax EGFr 51 PA# [002] 51 NATRECOR ® 51 TOCOSOL Paclitaxel 51 fidaxomicin Phase 51 GTC recombinant human 51 candidate SILENOR TM 51 Decadron 51 inhaled bronchodilator 51 maximal doses 51 CoTherix logo 51 cangrelor 51 EmbraceAC 51 IND enabling 51 solid tumors ZYBRESTAT 51 Luveris R Ovidrel R 51 Eniluracil 51 remifentanil 51 FACTIVE R gemifloxacin 51 Phase IIIb 51 oral prednisone 51 APEX PD 51 UGNE 51 preclinical pharmacokinetic 51 Perforomist TM Inhalation Solution 51 Heska Announces 51 investigational hepatitis B 51 Valcyte tablets 51 CML CP 51 phase Ib clinical 51 anaphylactic reactions bronchospasm 51 raloxifene Evista 51 LCP AtorFen 51 Peyronie disease Frozen Shoulder 51 SNS# T 51 TRAIL receptor antibody 51 chimeric monoclonal antibody 51 bevasiranib 51 vaginal lidocaine 51 postexposure 51 Vivaglobin 51 TRIST 51 Naloxone Hydrochloride 51 Moli# 51 Thalomid ® 51 FLUARIX 51 fludarabine cyclophosphamide 51 filgrastim 51 sodium thiosulfate STS 51 Anticonvulsant 51 MAb therapy 51 macrolide antibiotic 51 Phase 2b clinical 51 potent triglyceride lowering 51 XL# XL# XL# XL# 51 motesanib 51 pivotal bioequivalence 51 investigational monoclonal antibody 51 Erythropoiesis Stimulating Agents ESAs 51 Excellarate TM 51 ORE# 51 APTIMA HPV assay 51 mg RDEA# 51 aurora kinase 51 Phase Ia 51 maturation inhibitor 51 autoinjector device 51 candidate MyVax 51 Virulizin R 51 rFSH 51 visit www.targanta.com 51 arbaclofen 51 reteplase 51 mapatumumab 51 hyperplasia BPH 51 alpha 2A 51 posaconazole 51 thorough QT 51 ascending dose 51 Fast Track designations 51 glucokinase activator 51 Luramist 51 Stavzor TM 51 randomized blinded 51 tenofovir Viread 51 PRECISE Trial 51 doxorubicin docetaxel 51 lenalidomide dexamethasone 51 methylnaltrexone 51 Cerebril TM 51 warfarin sodium 51 ONCONASE R 51 morphine sulphate 51 treat opioid dependence 51 arterial thromboembolic 51 TriPath Oncology 51 C1 inhibitor rhC1INH 51 BEXXAR 50 celgosivir 50 Study NX# 50 PRIMO CABG 50 SMZ TMP 50 Amoxicillin PULSYS Phase III 50 haematologic 50 oral moxifloxacin 50 #D#C# 50 analgesic medications 50 buprenorphine implants 50 infused intravenously 50 vecuronium 50 TRISENOX ® 50 Pradaxa ® 50 skeletal muscle relaxant 50 OBPM 50 HGS ETR1 50 Allovectin 7 ® 50 efavirenz EFV 50 GRAVITAS trial 50 Phase 2b randomized 50 Phase III psoriasis 50 BrachySil 50 AlzheimAlert TM test 50 bupropion XL 50 TORISEL TM 50 palonosetron hydrochloride Injection Dacogen 50 intranasally administered 50 TRIOLEX ™ 50 Cethrin 50 olanzapine quetiapine 50 Aurora kinase inhibitor 50 macitentan 50 remission induction 50 Tapentadol 50 StemEx 50 eniluracil 50 release cysteamine bitartrate 50 antirheumatic 50 systemic hypotension 50 anagrelide hydrochloride 50 EVIZON 50 novel proprietary KL4 50 evaluating satraplatin 50 cMET inhibitor 50 Phase 2b monotherapy 50 myopathy rhabdomyolysis 50 glulisine 50 weekly intravenous infusions 50 pain palliation 50 Onconase 50 Edoxaban 50 triptorelin 50 recombinant interferon 50 CTA# Injection 50 Stedivaze